Bacil Pharma Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported revenue was INR 0.166 million compared to INR 0.24 million a year ago. Net loss was INR 0.776 million compared to INR 0.07 million a year ago. Basic loss per share from continuing operations was INR 0.13 compared to INR 0.01 a year ago. Diluted loss per share from continuing operations was INR 0.13 compared to INR 0.01 a year ago. For the six months, revenue was INR 0.335 million compared to INR 0.407 million a year ago. Net loss was INR 1.01 million compared to INR 0.131 million a year ago. Basic loss per share from continuing operations was INR 0.17 compared to INR 0.02 a year ago. Diluted loss per share from continuing operations was INR 0.17 compared to INR 0.02 a year ago.